Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy.

Kavitt RT, Penson DF, Vaezi MF
Dis Esophagus. 2014 27 (5): 418-23

PMID: 22947137 · PMCID: PMC3823713 · DOI:10.1111/j.1442-2050.2012.01409.x

MeSH Terms (14)

Androstadienes Anti-Inflammatory Agents Costs and Cost Analysis Decision Trees Deglutition Disorders Dilatation Endoscopy, Digestive System Eosinophilic Esophagitis Esophageal Stenosis Fluticasone Hospitalization Humans Metered Dose Inhalers Tennessee

Connections (2)

This publication is referenced by other Labnodes entities: